Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Importance of Periodical Screening for Primary Hyperparathyroidism in a Pituitary Tumor Cohort in Searching Patients With MEN1 and Its Genetic Profile.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists - 1 May 2022

Damianse Sabrina S P, Nascimento Gilvan C, Rocha Viviane C C, Nascimento Ana Gisélia P A C, Gaido Nadja C, Azulay Rossana S S, Dos Santos Wellyandra C, Rodrigues Vandilson P, Quidute Ana Rosa P, Magalhães Marcelo, Dos S Faria Manuel

Abstract excerpt

OBJECTIVE: Multiple endocrine neoplasia type 1 (MEN1) is a rare genetic syndrome characterized by parathyroid, anterior pituitary, and/or duodenopancreatic neuroendocrine tumors. Studies have indicated that investigating primary hyperparathyroidism (pHPT) with subsequent genetic screening may be an essential tool for the early diagnosis of MEN1 in patients with pituitary tumors (PTs). This study aimed to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Profile

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperparathyroidism, Primary

Share to Multiple Endocrine Neoplasia Type 1

Share to Mutation

Share to Pituitary Neoplasms

Source

Identifiers

PMID: 35247589
DOI: 10.1016/j.eprac.2022.02.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Importance of Periodical Screening for Primary Hyperparathyroidism in a Pituitary Tumor Cohort in Searching Patients With MEN1 and Its Genetic Profile.PMID 35247589Read ↗

Primary Hyperparathyroidism in Young People. When Should We Perform Genetic Testing for Multiple Endocrine Neoplasia 1 (MEN-1)?Semantic proximity Read ↗

Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.Semantic proximity Read ↗

Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study.Semantic proximity Read ↗

Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.Semantic proximity Read ↗

The Importance of an Early and Accurate MEN1 DiagnosisSemantic proximity Read ↗

Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese.Semantic proximity Read ↗

The clinical challenge of MEN1 phenocopies: insights from a multicentric national retrospective study.Semantic proximity Read ↗

MEN1 clinical background.Semantic proximity Read ↗

Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.Semantic proximity Read ↗

Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndromeSemantic proximity Read ↗

Characteristics of the Danish families with multiple endocrine neoplasia type 1.Semantic proximity Read ↗

Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.